Commerzbank Stock Holds Near Peak as UniCredit Tender Tactics Face Allegations and Defense Plan Advances

Commerzbank stock hovers near 52-week peak, but CEO Orlopp fights UniCredit's bid with a standalone strategy amid low genuine shareholder support and new ECB capital rules.

Commerzbank’s share price is hovering within striking distance of a multi-year high, but the battle for control between Frankfurt and Milan is growing more acrimonious. The stock closed at €38.67 on Friday and slipped to €38.26 on Monday – a 1.06% dip – leaving it just 0.46% below the 52-week peak of €38.85 reached on June 19. Over the past seven days the shares have gained 1.66%, while the year-to-date advance stands at a robust 34.27%. The technical backdrop remains supportive: the price is 4.84% above its 50-day moving average of €36.89 and comfortably ahead of the 200-day average of €34.40, while the Relative Strength Index of 57.5 signals neither overbought nor oversold conditions.

Yet the placid chart masks a deepening dispute over the true level of support for UniCredit’s takeover offer. Commerzbank has accused the Italian lender of artificially inflating its acceptance rate through a surge in securities lending just before the deadline. Internal analysis at the German bank shows an unusual spike in stock lending activity, which it believes was used by parties close to UniCredit to borrow shares en masse and then tender them into the offer. The move, Commerzbank argues, distorts the real market sentiment and creates a false picture of shareholder appetite.

UniCredit has reported a total acceptance rate of 17.6%, but Commerzbank’s own data tells a different story. According to the Frankfurt-based institution, fewer than 2% of independent institutional and private investors actually tendered their shares. The vast majority of the paper submitted, it says, came from UniCredit’s own orbit. For CEO Bettina Orlopp and her management team, the low level of genuine engagement is a clear signal that the core shareholder base rejects the Italian offer, reinforcing the rationale behind the standalone strategy dubbed “Momentum 2030,” which has been in place since February 2025.

Orlopp is now preparing a more muscular defense. Reports over the weekend indicate that the management is drawing up a strategic paper designed to make Commerzbank more attractive to investors than any offer from Milan. The plan includes a modest headcount reduction and significantly higher financial targets, aiming to push the bank’s market value persistently above a potential takeover premium. Only by lifting the share price sustainably, the reasoning goes, can the board convince shareholders that going it alone is the better bet.

But the defense strategy faces a new headwind from regulators. The European Central Bank recently warned lenders to be cautious with their capital reserves, citing geopolitical tensions in the Middle East and emerging risks from AI-driven trading algorithms. More concretely, a new systemic risk buffer took effect in July 2026, requiring an additional 2% capital cushion for loans backed by commercial real estate. Commerzbank is particularly exposed here because of its traditional focus on financing mid-sized companies and property projects. Analysts are now scrutinizing how much room the buffer will leave for dividends and share buybacks – precisely the tools Orlopp needs to win over investors.

On the legal front, UniCredit scored a victory over the weekend. The Frankfurt public prosecutor’s office rejected a criminal complaint filed by Commerzbank employees that alleged market manipulation related to the Italian bank’s share purchases. The investigators found no grounds to substantiate the claim, removing one legal hurdle for UniCredit and potentially increasing pressure on regulators.

Two key dates now dominate the outlook. The ECB is expected to decide during the current quarter on UniCredit’s application to raise its stake further, while Commerzbank will publish its second-quarter results on August 6. The earnings release will likely include more details on the defense strategy – and could prove pivotal in the battle for investor confidence. Until then, the tug-of-war over the true acceptance rate of the tender offer will continue to drive the narrative around the stock.